TL;DR
This study investigates the genetic basis of inherited retinal diseases caused by mutations in the PRPH2 gene, focusing on a large Chinese cohort and a comprehensive literature review. They found significant differences in the prevalence of retinitis pigmentosa (RP) and macular degeneration (MD) between Chinese and Caucasian populations, suggesting ethnic-specific genotype-phenotype correlations. This work provides valuable insights for diagnosing and counseling patients with PRPH2-related conditions.
What Problem Does This Paper Address?
Inherited retinal dystrophies (IRDs) are a group of genetic disorders that cause progressive vision loss. Mutations in the PRPH2 gene are a known cause of several IRDs, including retinitis pigmentosa (RP) and macular degeneration (MD). However, PRPH2-related diseases exhibit significant genetic and phenotypic heterogeneity, making diagnosis and prognosis challenging. While much research has focused on Caucasian populations, there's a need to understand how these genetic variations and their resulting phenotypes differ in other ethnic groups, particularly in China, where the prevalence of PRPH2 variants in IRDs has been reported to be lower than in European populations. This study aims to clarify the genotype-phenotype correlation of PRPH2 by analyzing a large Chinese cohort and integrating it with existing literature, highlighting potential population-specific differences.
Methods
The researchers employed a multi-pronged approach:
- In-house Exome Sequencing Data Analysis: They analyzed exome sequencing data from their own cohort to identify PRPH2 variants.
- Literature Review and Data Integration: They compiled all reported PRPH2 variants from existing literature and databases.
- Bioinformatic Prediction Tools: A suite of seven in silico prediction tools (REVEL, CADD, SIFT, LRT, Mutation Taster, FATHMM, PROVEAN) were used to assess the pathogenicity of missense variants.
- gnomAD Database Comparison: Variants were compared against the gnomAD database to assess their allele frequency in the general population, a key factor in determining pathogenicity.
- ACMG/AMP Guidelines: Variants were classified according to the American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) guidelines for variant interpretation.
- Sanger Sequencing and Co-segregation Analysis: Pathogenic or likely pathogenic variants identified in their cohort were confirmed using Sanger sequencing, and their inheritance patterns were tracked within families (co-segregation analysis).
- Clinical Data Summarization: Detailed clinical characteristics of affected individuals were collected and summarized.
- Statistical Analysis: Chi-square tests and Mann-Whitney U tests were used to compare phenotypic spectra and clinical characteristics between different groups.
Datasets
- In-house Exome Sequencing Data: Data from 10,530 recruited probands, including 1519 families with RP and 9011 unrelated individuals with other eye conditions.
- Publicly Available Databases:
- gnomAD (General Allele Frequency Database) for population allele frequency assessment.
- Human Gene Mutation Database (HGMD) for literature-based variant information.
- PubMed for literature searches.
Key Insights and Ideas
- Ethnic Differences in Phenotype: A striking finding is the difference in the primary phenotype associated with PRPH2 variants between Chinese and Caucasian populations. While macular degeneration (MD) is more common in Caucasian cohorts, retinitis pigmentosa (RP) is the predominant phenotype in the Chinese cohort studied. This suggests that ethnicity plays a crucial role in shaping the clinical presentation of PRPH2-related diseases.
- Variant Frequency Discrepancies: The most common PRPH2 variant identified in their Chinese cohort (p.G305Afs*19) differs from the most frequently reported variant in the literature (p.R172G), further underscoring population-specific genetic landscapes.
- Predictive Power of In Silico Tools: The study highlights that missense variants predicted to be highly damaging by multiple in silico tools and absent or rare in the gnomAD database are more strongly associated with RP. Conversely, variants with less severe predicted pathogenicity or higher allele frequencies in gnomAD are more likely to be associated with MD or unrelated phenotypes.
- Importance of Population-Specific Interpretation: The findings emphasize that interpreting PRPH2 variants requires considering population-specific data, as a variant's pathogenicity and associated phenotype might differ across ethnic groups.
Key Results
- Ten Pathogenic/Likely Pathogenic Variants: The study identified ten PRPH2 variants classified as pathogenic or likely pathogenic, found in 14 families.
- RP Dominance in Chinese Cohort: In their Chinese cohort, 63.8% of families with pathogenic/likely pathogenic PRPH2 variants were diagnosed with RP, a significantly higher proportion than reported in the literature (27.9%).
- MD Prevalence in Literature: In contrast, the literature review indicated that MD is the most common phenotype (45.2%) associated with PRPH2 variants, followed by RP (27.9%).
- Missense Variant Association: Patients with missense variants predicted as damaging by all seven in silico tools and absent in gnomAD were significantly more likely to develop RP (p = 0.001) compared to those with less severely predicted variants or those present in gnomAD.
- Common Variant in Cohort: The variant p.G305Afs*19 was the most frequent in their cohort, accounting for 33.3% of alleles, whereas p.R172G was the most common in the literature (11.6%).
Limitations and Future Work
- Limited Sample Size for Digenic Forms: While the study identified two families with a digenic pattern (involving PRPH2 and ROM1), the small sample size limits definitive conclusions about this specific inheritance mode.
- Need for Functional Studies: The authors acknowledge that in the absence of functional experiments, their genotype-phenotype correlations are based on computational predictions and clinical observations. Future work could involve functional studies to validate these predictions.
- Broader Population Studies: While this study provides valuable insights into the Chinese population, further research across diverse ethnic groups is needed to fully understand the global genotypic and phenotypic spectrum of PRPH2-related diseases.
- Long-Term Follow-up: The authors recommend long-term follow-up for all patients with detected PRPH2 variants, especially those with variants predicted as benign by multiple tools but lacking co-segregation data, to monitor for potential phenotype development.
Summary updated